Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000771322 | SCV000903589 | likely benign | Familial hypercholesterolemia | 2018-03-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000864864 | SCV001005732 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2024-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003303241 | SCV003997138 | likely benign | Cardiovascular phenotype | 2023-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000864864 | SCV004844166 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-12-18 | criteria provided, single submitter | clinical testing | |
GENin |
RCV000771322 | SCV005627227 | likely benign | Familial hypercholesterolemia | 2025-01-09 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted to impact splicing and occurs at a nucleotide which is not highly conserved. This variant has been classified as Likely Benign (BP4, BP7). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005240550 | SCV005884808 | benign | not specified | 2024-12-06 | criteria provided, single submitter | clinical testing |